From: Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer
Best Overall Tumor Response
Treated Population
(N = 87)*
Complete Response (CR)
1 (1.1)
Partial Response PR)
7 (8.0)
Response Rate (CR + PR)
8 (9.2)
Stable Disease/No Response (SD)
23 (26.4)
Progressive Disease (PD)
49 (56.3)
Not Evaluable